BLRX

BioLineRX
BLRX

Overview Fund Activity

25 hedge funds and large institutions have $8.87M invested in BioLineRX in 2016 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 3 closing their positions.

Holders
25
Holders Change
+1
Holders Change %
+4.17%
% of All Funds
0.67%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
7
Reduced
4
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
SM
1
Senvest Management
New York
$5.11M
2
VKH
2
Virtu KCG Holdings
New York
$174K
3
Morgan Stanley
3
Morgan Stanley
New York
$634K
4
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$56K
5
Alyeska Investment Group
5
Alyeska Investment Group
Illinois
$733K

Top Sellers

1
Millennium Management
1
Millennium Management
New York
$0
2
Deutsche Bank
2
Deutsche Bank
Germany
$245K
3
UBS Group
3
UBS Group
Switzerland
$9K
4
ARTA
4
A.R.T. Advisors
New York
$0
5
TSS
5
Two Sigma Securities
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
ARTA
26
A.R.T. Advisors
New York
– – -25,890 Closed
TSS
27
Two Sigma Securities
New York
– – -17,771 Closed
WCM
28
Wealthcare Capital Management
Virginia
$0 1,650 – –
1
2